SINOMED(SH:688108) 智通财经网·2025-08-21 12:29Core Insights - Sino Medical (688108.SH) reported a revenue of 240 million yuan for the first half of 2025, representing a year-on-year growth of 12.53% [1] - The net profit attributable to shareholders reached 13.84 million yuan, showing a significant increase of 296.54% year-on-year [1] - The basic earnings per share stood at 0.03 yuan [1] Revenue Breakdown - The coronary intervention business saw a revenue increase of 17.40% year-on-year, primarily driven by the substantial sales growth of two coronary stent products and balloon products that entered the centralized procurement scope during the reporting period [1] - The neuro-intervention business experienced a revenue growth of 6.25% year-on-year, mainly due to the sales growth of newly launched products from the previous year [1]